About

Born in CA, I did my undergraduate studies in bioengineering at UC Berkeley working on biomaterials and 3D models for heart development (1-3). During my PhD, I have worked on building in vitro models and applying RNA-seq to study skeletal muscle disease, regeneration, and cell therapies (4-6).

Publications:

1. Wang, J., et al, 2021. Three-dimensional tissue-engineered human skeletal muscle model of Pompe disease. Communications Biology- Nature
2. Ma, Z.&, Wang, J.&, Loskill, P., Huebsch, N., Koo, S., Svedlund, F.L., Marks, N.C., Hua, E.W., Grigoropoulos, C.P., Conklin, B.R. and Healy, K.E., 2015. Self-organizing human cardiac microchambers mediated by geometric confinement. Nature Communications, 6. &equally contributing co-1st authors
3. Maclean, Lau, Ozergun, O’Shea, Wang J., et al., 2017. Galactose-functionalised PCL nanofibre scaffolds to attenuate inflammatory action of astrocytes in vitro and in vivo. Journal of Materials Chemistry B
4. Hoang, P., Wang, J., et al.,2018. Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells. Nature Protocols.
5. Wang J., et al., 2019. Engineered skeletal muscles for disease modeling and drug discovery. Biomaterials.
6. Khodabukus, A., Prabhu, N., Wang, J., et al., 2018. In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease. Advanced Healthcare Materials
7. Juhas, M., Abutaleb N., Wang, J., et al.,2018. Incorporation of macrophages into engineered skeletal muscle enables enhanced muscle regeneration. Nature biomedical engineering.
8. Khodabukus, A., Kaza, A., Wang, J., et al., 2020. Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers. Toxicological Sciences

In vitro model for screening drugs for heart development [1]